These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7272867)

  • 21. Plasmapheresis therapy in immunologically mediated rheumatic and renal diseases.
    Balow JE; Austin HA; Tsokos GC
    Clin Immunol Rev; 1984; 3(2):235-72. PubMed ID: 6241117
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic plasmapheresis and plasma exchange.
    Patten E
    Crit Rev Clin Lab Sci; 1986; 23(2):147-75. PubMed ID: 3081298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monthly pulses of methylprednisolone in SLE nephritis.
    Liebling MR; McLaughlin K; Boonsue S; Kasdin J; Barnett EV
    J Rheumatol; 1982; 9(4):543-8. PubMed ID: 7131454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically occult diffuse proliferative lupus nephritis. An age-related phenomenon.
    Eiser AR; Katz SM; Swartz C
    Arch Intern Med; 1979 Sep; 139(9):1022-5. PubMed ID: 475519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic plasmapheresis. Possible indications].
    Nielsen LP
    Ugeskr Laeger; 1983 Apr; 145(14):1041-7. PubMed ID: 6683438
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse proliferative lupus glomerulonephritis. Recovery from prolonged renal failure.
    Moore WS; Guggenheim SJ; Anderson RJ
    JAMA; 1980 Jul; 244(1):63-5. PubMed ID: 7382059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term follow-up on the treatment of diffuse proliferative glomerulonephritis in patients with systemic lupus erythematosus].
    Golan E; Weintal I; Bernheim J; Ben-Chetrit S; Bernheim J
    Harefuah; 2002 Apr; 141(4):324-8, 412. PubMed ID: 12017882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasmapheresis, an aid in the treatment of patients with active systematic lupus erythematosus?].
    Houwert DA; Kater L; Struyvenberg A
    Ned Tijdschr Geneeskd; 1978 May; 122(19):678-81. PubMed ID: 148592
    [No Abstract]   [Full Text] [Related]  

  • 31. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
    Mok CC; To CH; Mak A; Ma KM
    Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma exchange in the treatment of lupus nephritis.
    Moriconi L; Ferri C; Fanara G; Migliorini P; Vitali C; Cioni L; Gremignai G; Bombardieri S
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():35-8. PubMed ID: 6642734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apheresis in lupus nephritis.
    Mistry-Burchardi N; Schönermarck U; Samtleben W
    Ther Apher; 2001 Jun; 5(3):161-70. PubMed ID: 11467751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression.
    Leaker BR; Becker GJ; Dowling JP; Kincaid-Smith PS
    Clin Nephrol; 1986 May; 25(5):236-44. PubMed ID: 3720034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
    Schneider M; Berning T; Waldendorf M; Glaser J; Gerlach U
    J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N; Bambauer R; Jost W; Schäfer M
    Monatsschr Kinderheilkd; 1990 Jul; 138(7):395-8. PubMed ID: 2398909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus. Case report and literature review from the plasmapheresis era.
    Stricker RB; Davis JA; Gershow J; Yamamoto KS; Kiprov DD
    J Rheumatol; 1992 Sep; 19(9):1469-73. PubMed ID: 1433019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of systemic lupus erythematosus.
    Miller ML
    Curr Opin Rheumatol; 1992 Oct; 4(5):693-9. PubMed ID: 1419504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.